Larkin v. CVS Caremark

On September 3, 2025, Plaintiffs Dennis Larkin and Danielle Gosline filed a class action lawsuit against Caremark RX, L.L.C. (“CVS Caremark”) under the Employee Retirement Income Security Act of 1974 (“ERISA”). Plaintiffs belong to an employer-sponsored health benefit plan for which CVS Caremark acts as a pharmacy benefit manager (“PBM”). Plaintiffs’ requests for coverage of Zepbound (tirzepatide) were denied by CVS Caremark due to alleged lack of medical necessity and not being covered under the plan, in violation of ERISA and the terms of the applicable plan documents.

Read more about the complaint here.

Read more about the lawsuit:

• A Pharmacy Benefit Manager Stopped Covering a GLP-1 for Obesity. Now There’s a Lawsuit, CNN Health (September 5, 2025).
• CVS Caremark Faces Lawsuit for Favoring Wegovy Over Zepbound, Bloomberg Law (September 4, 2025).
• CVS Caremark Sued Over GLP-1 drug Switch, Citing ERISA Breach, BenefitsPro (September 8, 2025).

Berger Montague is one of the nation’s preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law, employment law, securities, and whistleblower cases, among many other practice areas. For over 55 years, Berger Montague has played leading roles in precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago; Malvern, PA; Minneapolis; San Diego; San Francisco; Toronto, Canada; Washington, D.C., and Wilmington, DE.